Roger Waters: Antisemitism is odious, and I condemn it
(London, UK): Statement by Mr George Roger Waters dated 16.03.2023:
“My lawyers are taking steps to ensure that my concerts in Munich and Frankfurt in May 2023 take place as contracted. Human rights and freedom of speech for all peoples under German law must prevail, which is why I’m taking this stance to ensure the will of the few will not prevent me from performing in Frankfurt and Munich.
I am taking the unprecedented step of appealing to the law to protect me from the unconstitutional actions of two authorities which seem to rely upon the fundamentally false accusation that has been made against me; namely that I am antisemitic.
I want to state for the record and once and for all that I am not and never have been antisemitic and nothing that anyone can say or publish will alter that. My well-publicized views relate entirely to the policies and actions of the Israeli government and not with the peoples of Israel. Antisemitism is odious and racist, and I condemn it, along with all forms of racism unreservedly.
I am not going to and do not need to keep making my position clear on this issue. I am confident that truth and the law will prevail and that these authorities will not succeed in denying any of my basic human rights.”
Mark Fenwick Management – London
on behalf of Mr George Roger Waters
HÖCKER Rechtsanwälte PartGmbB
Rechtsanwalt Prof. Dr. Ralf Höcker
Rechtsanwalt Michael Fengler
Om news aktuell GmbH
+49 (0)40 4113-32589http://www.newsaktuell.de
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
TXOne Networks Widens the Scope of Network Protection for OT Environments with Launch of New Product EdgeIPS 10320.3.2023 09:54:39 CET | Pressemelding
The new model, EdgeIPS 103, offers the latest flexible, transparent network security solution with elevated throughput, smarter, OT native networking security appliances and contingency protocols to protect critical assets in OT environments.
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories20.3.2023 09:43:28 CET | Press release
Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally (Munich / London / Athens) – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company Clinigen Limitedto acquire Lamda Laboratories S.A. in Athens. The acquisition of Lamda Laboratories significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services for its global pharmaceutical customers. Lamda has not only acted as Clinigen’s sole development center but has also established a well-earned reputation as a highly reliable contract development organization (CDO) for third party customers. Under a pharmaceutical development services agreemen
Roger Waters fights back15.3.2023 09:08:58 CET | Press release
Roger Waters defends freedom of speech and takes legal action against proposed concert cancellations in Frankfurt and Munich.
NP-Invest GmbH: Extreme swimmer braves the forces of nature / Nathalie Pohl is the first German woman to cross New Zealand’s Cook Strait2.3.2023 10:30:18 CET | Pressemelding
- Picture is available at AP Images (http://www.apimages.com) – (Marburg, Germany): It seems as if neither a cyclone nor an earthquake can stop her and her ambition is limitless: In her third attempt, extreme swimmer Nathalie Pohl has successfully managed to cross New Zealand’s Cook Strait as the first German woman and the fastest European woman to do so. With an exceptional time of 06:33:00 hours, the 28-year-old reached the finish line on Ohau Bay at 4.30 p. m. local time (UTC+13) on 1 March. A very hazardous channel The passage between Ohau Bay on New Zealand’s North Island and Arapawa Island on its South Island is considered particularly dangerous. Only 130 extreme swimmers worldwide have ever successfully made the crossing. In addition to being a busy shipping lane, there are often sharks to contend with and significant seismic shifts on the seabed, which can cause dangerous currents. The Cook Strait is also known for its rough seas. Strong currents can add many hours to the swim.
Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan2.3.2023 09:12:54 CET | Pressemelding
Adragos Pharma now third largest pure-play CDMO in the Japanese market Long-term agreement with Sanofi secures local healthcare supply Munich / Paris / Tokyo, March 02, 2023 – Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading pharmaceutical manufacturing facilities from Sanofi K.K. The transaction makes Adragos Pharma the third largest pure-play contract manufacturer in Japan, one of its three core markets. The acquisition also kicks off a long-term supply agreement between the CDMO and Sanofi. Kawagoe Pharma will continue to produce for Sanofi and the Japanese market as a strategic partner, thus playing an essential role for the local healthcare system. The official handover of the production facility took place yesterday in the presence of the workforce, which will remain at the site, as well as of representatives of both companies. The Kawagoe site near Tokyo is one of the largest and most te
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom